#CardiovascularOutcomes
LightNews LightNews
tumscvdri.bsky.social
Global trends in DPP-4 inhibitor research focus on #CardiovascularOutcomes like #HeartFailure and #AtrialFibrillation in type 2 #diabetes. Leading institutions and authors drive this evolving field. #DPP4Inhibitors journals.lww.com/annals-of-me...
Global research trends on DPP-4 inhibitors and... : Annals of Medicine and Surgery
cular safety and efficacy. This bibliometric analysis aims to provide insights into the global research landscape on DPP-4 inhibitors and cardiovascular outcomes (CVOs). Methods: A bibliometric ana...
journals.lww.com
July 28, 2025 at 5:22 AM
itmat.bsky.social
Penn Medicine #BioBank growing its impact: Discerning early aortic #aging from imaging data with links to adverse #CardiacRemodeling and poor #CardiovascularOutcomes www.ahajournals.org/doi/10.1161/... @ThePMBioBank #PMBB #TranslationalScience
Early Vascular Aging Determined by 3-Dimensional Aortic Geometry: Genetic Determinants and Clinical Consequences | Circulation
BACKGROUND: Vascular aging is an important phenotype characterized by structural and geometric remodeling. Some individuals exhibit supernormal vascular aging, associated with improved cardiovascular ...
www.ahajournals.org
July 18, 2025 at 5:45 PM
gmj-georgia.bsky.social
Breaking: GLP-1 medications reduce deaths and amputations in type 2 diabetes patients with peripheral artery di…

#Amputationprevention #Cardiovascularoutcomes #GLP1receptoragonists #Peripheralarterydisease #Type2diabetes

#Amputationprevention #Cardiovascularoutcomes #GLP1receptoragonists #Perip…
GLP-1 drugs reduce death risk in diabetes with leg artery disease
Breaking: GLP-1 medications reduce deaths and amputations in type 2 diabetes patients with peripheral artery di… #Amputationprevention #Cardiovascularoutcomes #GLP1receptoragonists #Peripheralarterydisease #Type2diabetes
news.gmj.ge
September 14, 2026 at 7:26 PM
gmj-georgia.bsky.social
Breaking: GLP-1 medications reduce deaths and amputations in type 2 diabetes patients with peripheral artery di…

#Amputationprevention #Cardiovascularoutcomes #GLP1receptoragonists #Peripheralarterydisease #Type2diabetes

#Amputationprevention #Cardiovascularoutcomes #GLP1receptoragonists #Perip…
GLP-1 drugs reduce death risk in diabetes with leg artery disease
Breaking: GLP-1 medications reduce deaths and amputations in type 2 diabetes patients with peripheral artery di… #Amputationprevention #Cardiovascularoutcomes #GLP1receptoragonists #Peripheralarterydisease #Type2diabetes
news.gmj.ge
September 3, 2026 at 10:41 PM
miriam96.bsky.social
Prescription Weight Loss: Costly vs Heart-Saving

https://weightlossfacts.online/prescription-weight-loss-costly-vs-heart-saving/?utm_source=bluesky&utm_medium=social
#semaglutidedosetitration #cardiovascularoutcomes #heartdiseaseriskreduction
August 26, 2026 at 2:24 AM
orson-johnson.bsky.social
70% Obesity Treatment Breaks Semaglutide Dose Matters

https://nexusbase.site/semaglutide-dose-cardiovascular-benefit/?utm_source=bluesky&utm_medium=social
#semaglutide #cardiovascularoutcomes #alignmorecloselywithattaineddose
August 19, 2026 at 2:33 PM
philip-jameson.bsky.social
The Biggest Lie About Semaglutide's Dose

https://ozem.help/the-biggest-lie-about-semaglutides-dose/?utm_source=bluesky&utm_medium=social
#semaglutide #cardiovascularoutcomes #attaineddose
August 19, 2026 at 2:36 PM
miriam96.bsky.social
5 Reasons Semaglutide Doses Surpass Weight Loss

https://glpfacts.online/5-reasons-semglutide-doses-surpass-weight-loss/?utm_source=bluesky&utm_medium=social
#semaglutide #cardiovascularoutcomes #alignmorecloselywithattaineddose
August 19, 2026 at 2:34 PM
annabel-baker.bsky.social
Prescription Weight Loss Hidden Dose Danger Exposed

https://glpdrugs.site/prescription-weight-loss-hidden-dose-danger-expose/?utm_source=bluesky&utm_medium=social
#semaglutide #cardiovascularoutcomes #attaineddose
August 19, 2026 at 2:32 PM
4040rec.bsky.social
#Bayer #Kerendia #finerenone #NICE #cardiovasculardiseases #chronicheartfailure #CHF #NICEFinaldraftguidance #symptomaticCHF #heartfailurewithmildlyreducedejectionfraction #HFmrEF #heartfailurewithpreservedejectionfraction #HFpEF #MHRA #FINEARTSHFstudy #cardiovascularoutcomes
zurl.co/sk420
Bayer's Kerendia on course for NHS use in heart failure
Up to 280,000 people with heart failure could soon be eligible for NHS treatment with Bayer's Kerendia, following new NICE guidance.
pharmaphorum.com
July 20, 2026 at 9:22 AM
4040rec.bsky.social
#weightloss #weightlossmedications #obesity #Lilly #EliLilly #hearthealthdata #Mounjaro #tirzepatide #GLP1agonists #cardiovascularoutcomes #SURPASSCVOTtrial #dualGLP1GIPagonist #GLP1drug #MACE #heartattackprevention #strokeprevention #MACEendpoints #CVD #cardiometabolichealth
zurl.co/9w8Sk
Lilly trumpets heart health data with Mounjaro
Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 drugs for diabetes, with new data for Mounjaro on cardiovascular outcomes.
zurl.co
August 6, 2025 at 9:09 AM
itmat.bsky.social
#MicrotubularNetwork largely mediates #CardiacRemodeling of #Cardiomyocytes in response to #MechanicalLoad doi.org/10.1016/j.jm... #MyocardialInfarction #CardiovascularOutcomes #TranslationalScience
Redirecting
doi.org
April 14, 2026 at 7:05 PM